Hpv Probe Detection
Hpv Probe Detection - Related Videos
03:26
Probe Hybridization and Signal Amplification in RNA In Situ Hybridization: A Technique for Detecting Specific RNA Sequences in Tissue Sections
0 Views •
2023
This video describes a sequential hybridization strategy that involves hybridizing mRNA probes to specific target mRNA. Following probe hybridization, signal amplification is performed to enhance resolution via reduction of signal-to-noise ratio during RNA-CISH of histological samples.
06:58
Synthesis of an In vivo MRI-detectable Apoptosis Probe
0 Views •
Cited by 3 •
2012
Early detection of apoptosis may identify at-risk cell populations in a variety of diseases. Here we demonstrate a method to link an early apoptosis-detection protein (Annexin V) to a MRI-detectable iron oxide nanoparticle (SPIO). This method may be extended to other proteins of interest to generate MRI-detectable molecular imaging probes.
10:26
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
0 Views •
Cited by 41 •
2014
The presence of high-risk HPV in head and neck tumor tissue is associated with favorable outcomes. The recently developed RNA in situ hybridization technique called RNAscope allows direct visualization of HPV E6/E7 mRNA in FFPE tissue sections.
12:52
Iridium(III) Luminescent Probe for Detection of the Malarial Protein Biomarker Histidine Rich Protein-II
0 Views •
Cited by 4 •
2015
Robust detection reagents are of increasing necessity for developing new malaria diagnostic tools. An iridium(III) probe was designed that emits long-lasting luminescent signal in the presence of a histidine-rich malarial protein biomarker. Detection of the protein either in solution or immobilized on a magnetic particle affords flexibility in application.
11:15
In Situ Detection of Bacteria within Paraffin-embedded Tissues Using a Digoxin-labeled DNA Probe Targeting 16S rRNA
0 Views •
Cited by 16 •
2015
Here a method to localize bacteria within paraffin-embedded tissues using DIG-labeled 16S rRNA-targeting DNA probes has been described. This protocol can be applied to study the role of bacteria in various diseases such as periodontitis, cancers, and inflammatory immune diseases.
FAQs
Specificity comes from complementary base pairing between the labeled probe and its matching HPV DNA or RNA sequence. A probe is designed around a selected viral sequence, so the resulting signal reflects recognition of that target rather than simply the presence of cellular material. This sequence-based interaction allows investigators to examine HPV-related molecular findings in cancer research samples.
The label converts a probe-target interaction into an observable measurement. After the probe binds its complementary HPV sequence, the label can support fluorescence-based detection, microscopy, or another detection system. This connection between molecular binding and a measurable signal enables investigators to locate or assess HPV genetic material within cells, tissues, or other clinical samples.
Probe design determines which HPV genetic sequence is recognized. By selecting probes complementary to particular HPV sequences, investigators can examine viral genotype-related differences rather than treating all HPV signals as identical. The same approach can also support studies of viral persistence, because repeated or distributed signals provide molecular evidence for investigating HPV-associated changes across experimental or clinical samples.
The method can be applied to cells, tissues, and clinical samples, allowing HPV-related molecular findings to be studied in different biological contexts. Tissue-based analysis can help assess where viral genetic material occurs, while cellular or clinical samples may support broader investigations of HPV presence and genotype. The selected sample type therefore shapes the biological interpretation of the signal.
Detection may rely on fluorescence, microscopy, or other systems capable of measuring the probe-associated signal. These readouts provide evidence that a complementary HPV sequence was recognized and can be examined in relation to sample location or distribution. In cancer research, the resulting pattern contributes to analyses of viral presence, tissue distribution, and possible persistence.
HPV probe detection supplies molecular evidence for studying viral oncogenesis and tumor biology in HPV-associated cancers. Researchers can use findings on viral presence, genotype, distribution, or persistence to support biomarker development and disease classification. The method also helps connect HPV-related genetic material with changes observed in experimental or clinical samples, strengthening investigation of tumor-associated biology.